call 1800 257 600 email [email protected]

Clinical Trials

Cancer Type

State

Phase

Treatment

Inhibitor

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

NCT 05920356 Brief Summary The primary objective of this study is to…

Read more arrow_forward

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer (Krascendo 2)

NCT 06793215 Brief Summary The purpose of this study is to evaluate…

Read more arrow_forward

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

NCT 04802759 Brief Summary This is a Phase Ib/II, open-label, multicenter, randomized…

Read more arrow_forward

A Study Evaluating the Efficacy and Safety of Pirtobrutinib in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT 06588478 Brief Summary The main purpose of this study is to…

Read more arrow_forward

A Study Evaluating the Safety and Efficacy of Multiple Treatments in Participants With Multiple Myeloma (PLYCOM)

NCT 05583617 Brief Summary CO43923 is a platform study that will evaluate…

Read more arrow_forward

A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

NCT 04929223 Brief Summary This open-label, exploratory study is designed to evaluate…

Read more arrow_forward

A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation (Krascendo 170)

NCT 05789082 Brief Summary The purpose of this study is to evaluate…

Read more arrow_forward

A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)

NCT 05927571 Brief Summary The purpose of the study is to evaluate…

Read more arrow_forward

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT 05981703 Brief Summary This is an open-label, multicenter, and nonrandomized dose…

Read more arrow_forward

A Study of ABT-301 Plus Tislelizumab With Bevacizumab in pMMR/Non-MSI-H Locally Advanced or mCRC

NCT 07244705 Brief Summary The goal of this clinical trial is to…

Read more arrow_forward

Knowledgebase

Cancer Types Cancer Services Health Professionals Clinical Trials

How we help you

Our support knows no limits, which means we do whatever it takes to be there for all you need.

How we help you View the Rare Cancer Support Guide

Can’t find what you’re looking for?

We have a friendly team available to chat about any questions you may have, or just to lend an ear if you’re having a tough time.

Call 1800 257 600 Have us call you